Alcohol Consumption Among Adults With a Cancer Diagnosis in the All of Us Research Program
JAMA Network Open · 10.08.2023 · 6 (8) · e2328328
DOI: 10.1001/jamanetworkopen.2023.28328 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 10.08.2023. Verfasst von Mengyao Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health Sciences, Department of Surgery, Washington University in St Louis School of Medicine, St Louis, Missouri. Hauptthemen laut MEDLINE: Alcoholism, Binge Drinking, Population Health, Neoplasms. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Importance Alcohol consumption is associated with adverse oncologic and treatment outcomes among individuals with a diagnosis of cancer. As a key modifiable behavioral factor, alcohol consumption patterns among cancer survivors, especially during treatment, remain underexplored in the United States.
Objective
To comprehensively characterize alcohol consumption patterns among US cancer survivors. Design, Setting, and Participants This cross-sectional study used data from May 6, 2018, to January 1, 2022, from the National Institutes of Health All of Us Research Program, a diverse US cohort with electronic health record (EHR) linkage, and included 15 199 participants who reported a cancer diagnosis and 1839 patients among a subset with EHR data who underwent treatment within the past year of the baseline survey. Data analysis was performed from October 1, 2022, to January 31, 2023. Main Outcomes and Measures Prevalence of current drinking and of risky drinking behaviors, including exceeding moderate drinking (>2 drinks on a typical drinking day), binge drinking (≥6 drinks on 1 occasion), and hazardous drinking (Alcohol Use Disorders Identification Test–Consumption [AUDIT-C] score ≥3 for women or ≥4 for men).
Results
This study included 15 199 adults (mean [SD] age at baseline, 63.1 [13.0] years; 9508 women [62.6%]) with a cancer diagnosis. Overall, 11 815 cancer survivors (77.7%) were current drinkers. Among current drinkers, 1541 (13.0%) exceeded moderate drinking, 2812 (23.8%) reported binge drinking, and 4527 (38.3%) engaged in hazardous drinking. After multivariable adjustment, survivors who were younger than 65 years, men, or of Hispanic ethnicity or who received a diagnosis before 18 years of age or ever smoked were more likely to exceed moderate drinking (aged <50 years: odds ratio [OR], 2.90 [95% CI, 2.41-3.48]; aged 50-64 years: OR, 1.84 [95% CI, 1.58-2.15]; men: OR, 2.38 [95% CI, 2.09-2.72]; Hispanic ethnicity: OR, 1.31 [95% CI, 1.04-1.64]; aged <18 years at diagnosis: OR, 1.52 [95% CI, 1.04-2.24]; former smokers: OR, 2.46 [95% CI, 2.16-2.79]; current smokers: OR, 4.14 [95% CI, 3.40-5.04]) or binge drink (aged <50 years: OR, 4.46 [95% CI, 3.85-5.15]; aged 50-64 years: OR, 2.15 [95% CI, 1.90-2.43]; men: OR, 2.10 [95% CI, 1.89-2.34]; Hispanic ethnicity: OR, 1.31 [95% CI, 1.09-1.58]; aged <18 years at diagnosis: OR, 1.71 [95% CI, 1.24-2.35]; former smokers: OR, 1.69 [95% CI, 1.53-1.87]; current smokers: OR, 2.27 [95% CI, 1.91-2.71]). Survivors with cancer diagnosed before 18 years of age or who ever smoked were more likely to be hazardous drinkers (aged <18 years at diagnosis: OR, 1.52 [95% CI, 1.11-2.08]; former smokers: OR, 1.83 [95% CI, 1.68-1.99]; current smokers: OR, 2.13 [95% CI, 1.79-2.53]). Of 1839 survivors receiving treatment as captured in the EHR, 1405 (76.4%) were current drinkers, and among these, 170 (12.1%) exceeded moderate drinking, 329 (23.4%) reported binge drinking, and 540 (38.4%) engaged in hazardous drinking, with similar prevalence across different types of cancer treatment. Conclusions and Relevance This cross-sectional study of a diverse US cohort suggests that alcohol consumption and risky drinking behaviors were common among cancer survivors, even among individuals receiving treatment. Given the adverse treatment and oncologic outcomes associated with alcohol consumption, additional research and implementation studies are critical in addressing this emerging concern among cancer survivors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Public Health Sciences, Department of Surgery, Washington University in St Louis School of Medicine, St Louis, Missouri.
- Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison.
- University of Wisconsin Carbone Cancer Center, Madison.
- Alvin J. Siteman Cancer Center, Washington University in St Louis School of Medicine, St Louis, Missouri.
- Division of Gastroenterology, Department of Medicine, Washington University in St Louis School of Medicine, St Louis, Missouri.
Förderung
- NCI NIH HHS
Zitieren
APA
Shi, M., Luo, C., Oduyale, O. K., Zong, X., LoConte, N. K., & Cao, Y. (2023). Alcohol Consumption Among Adults With a Cancer Diagnosis in the All of Us Research Program. JAMA Network Open, 6(8), e2328328. https://doi.org/10.1001/jamanetworkopen.2023.28328
Vancouver
Shi M, Luo C, Oduyale OK, Zong X, LoConte NK, Cao Y. Alcohol Consumption Among Adults With a Cancer Diagnosis in the All of Us Research Program. JAMA Network Open. 2023;6(8):e2328328. doi:10.1001/jamanetworkopen.2023.28328
BibTeX
@article{Shi2023,
author = {Shi, Mengyao and Luo, Chongliang and Oduyale, Oluseye K and Zong, Xiaoyu and LoConte, Noelle K and Cao, Yin},
title = {Alcohol Consumption Among Adults With a Cancer Diagnosis in the All of Us Research Program},
journal = {JAMA Network Open},
year = {2023},
volume = {6},
number = {8},
pages = {e2328328},
doi = {10.1001/jamanetworkopen.2023.28328}
}
EUVIMED